ARIDIS PHARMACEUTICALS INC (ARDS)
US0403341045 - Common Stock
| TTM (2023-3-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -29.42M | -30.37M | -42.19M | -22.33M | -29.68M | |||
| Depreciation Amortization | 443.00K | 487.00K | 440.00K | 340.00K | 340.00K | |||
| Change In Working Capital | 4.80M | -1.30M | 10.52M | -620.00K | 18.22M | |||
| Interest Paid | N/A | N/A | N/A | N/A | N/A | |||
| Taxes Paid | 20.00K | 19.00K | 0.00 | 0.00 | 0.00 | |||
| Other non cash items | 1.21M | 2.06M | 8.31M | 2.14M | 2.96M | |||
| OPERATING CASH FLOW | -22.96M | -29.13M | -22.94M | -20.48M | -8.16M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -61.00K | -82.00K | -530.00K | -370.00K | -170.00K | |||
| Other Investing Activity | N/A | N/A | N/A | N/A | 0.00 | |||
| INVESTING CASH FLOW | -61.00K | -82.00K | -530.00K | -370.00K | -170.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 0.00 | 5.00M | 5.00M | 720.00K | N/A | |||
| Stock Issued/Repurchased | 14.67M | 12.61M | 29.72M | 7.96M | 4.99M | |||
| Other Financing Activity | -4.07M | -2.83M | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | 10.60M | 14.78M | 34.72M | 8.68M | 4.99M | |||
| CHANGE IN CASH | -12.42M | -14.43M | 11.25M | -12.17M | -3.34M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -22.96M | -29.13M | -22.94M | -20.48M | -8.16M | |||
| Capital Expenditure | -61.00K | -82.00K | -530.00K | -370.00K | -170.00K | |||
| FREE CASH FLOW | -23.02M | -29.21M | -23.47M | -20.85M | -8.33M | |||
All data in USD